Leica Biosystems to Market Novacyt's Cancer Test in China

Leica Biosystems, a German company specializing in pathology products, gained exclusive rights to distribute Novacyt’s cervical cancer test, NOVAPrep®, in Greater China. Novacyt is a French medical device maker that develops diagnostics for cancer and infectious diseases. NOVAPrep was recently approved for use in China. Novacyt said marketing the test in China will be "transformative" for the company. More details.... Share this with colleagues: // //